|
Delayed
Berne S.E.
|
5-day change | 1st Jan Change | ||
| - CHF | -.--% |
|
-.--% | - |
| 03/09 | DocMorris AG : Gets a Neutral rating from Jefferies | ZD |
| 26/08 | DocMorris AG : From a Buy to Neutral rating by Jefferies | ZD |
Company Valuation: DocMorris AG
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,412 | 320.6 | 860.2 | 257.7 | 289.2 | 506.9 | - | - |
| Change | - | -86.71% | 168.32% | -70.05% | 12.22% | 75.3% | - | - |
| Enterprise Value (EV) 1 | 2,714 | 723.2 | 1,137 | 486.1 | 426.8 | 709.2 | 739 | 720.2 |
| Change | - | -73.36% | 57.22% | -57.25% | -12.21% | 66.19% | 4.2% | -2.55% |
| P/E | -10.1x | -1.61x | 10.5x | -2.42x | -1.71x | -6.27x | -13.9x | -230x |
| PBR | 5.44x | 0.84x | 2.01x | 0.69x | 0.7x | 1.57x | 1.54x | 1.72x |
| PEG | - | 0.1x | -0x | 0x | 0x | 0.1x | 0.3x | 2.4x |
| Capitalization / Revenue | 1.4x | 0.2x | 0.89x | 0.25x | 0.26x | 0.4x | 0.36x | 0.33x |
| EV / Revenue | 1.57x | 0.45x | 1.18x | 0.48x | 0.38x | 0.56x | 0.52x | 0.47x |
| EV / EBITDA | -19x | -9.31x | -29.6x | -10x | -8.85x | -47.7x | 34.9x | 13.7x |
| EV / EBIT | -14x | -5.15x | -13.7x | -5.41x | -4.41x | -11.1x | -28.5x | 160x |
| EV / FCF | -14x | -3.87x | -9.88x | -8.81x | -3.68x | -8.98x | -25x | -60.2x |
| FCF Yield | -7.15% | -25.9% | -10.1% | -11.4% | -27.2% | -11.1% | -4.01% | -1.66% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -23.4 | -15.88 | 7.05 | -8.25 | -3.47 | -1.601 | -0.7243 | -0.0437 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 1,726 | 1,608 | 966.9 | 1,017 | 1,124 | 1,261 | 1,425 | 1,540 |
| EBITDA 1 | -142.6 | -77.7 | -38.4 | -48.6 | -48.24 | -14.86 | 21.19 | 52.41 |
| EBIT 1 | -193.8 | -140.3 | -83.2 | -89.8 | -96.86 | -63.81 | -25.94 | 4.495 |
| Net income 1 | -225.7 | -171.1 | 82.2 | -97.3 | -134.4 | -85.9 | -39.53 | -9.923 |
| Net Debt 1 | 302.8 | 402.6 | 276.8 | 228.4 | 137.6 | 202.3 | 232.1 | 213.3 |
| Reference price 2 | 235.50 | 25.56 | 73.75 | 19.98 | 5.95 | 10.04 | 10.04 | 10.04 |
| Nbr of stocks (in thousands) | 10,240 | 12,543 | 11,664 | 12,897 | 48,599 | 50,489 | - | - |
| Announcement Date | 24/03/22 | 24/03/23 | 20/03/24 | 12/03/25 | 18/03/26 | - | - | - |
1CHF in Million2CHF
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 16.76x | 0.68x | 10.09x | -.--% | 1.49TCr | |
| 16.67x | 0.75x | 7.81x | 2.23% | 656.89Cr | |
| 21.06x | 0.8x | 13.55x | 1.06% | 652.59Cr | |
| 14.65x | 0.9x | 6.21x | 2.87% | 412.19Cr | |
| 14.33x | 1.23x | 7.53x | 5.61% | 318.82Cr | |
| 14.12x | 0.6x | 4.6x | 5.12% | 312.36Cr | |
| 13.48x | 0.81x | 6.07x | 4.78% | 286.11Cr | |
| 33.21x | - | - | - | 258.25Cr | |
| Average | 18.04x | 0.82x | 7.98x | 3.1% | 548.99Cr | |
| Weighted average by Cap. | 17.58x | 0.78x | 9.00x | 1.96% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ROSE Stock
- ROSE Stock
- Valuation DocMorris AG
Select your edition
All financial news and data tailored to specific country editions
